ARCHIVED - Assisted Human Reproduction Canada

• Previous Page
• Table of Contents
• Next Page

This page has been archived.

Section II: Analysis of Program Activities by Strategic Outcome

Analysis by Program Activity

Strategic Outcome

Protection and promotion of the health and safety of Canadians against the risks associated with assisted human reproduction technologies.

Program Activity: Licensing and Enforcement of a Regulatory Framework for Assisted Human Reproduction Technologies.

Financial Resources (in $ thousands)

Planned Spending	Authorities	Actual Spending
6,076	6,076	3,051

Human Resources

Planned	Actual	Difference
22 FTEs	4 FTEs	18 FTEs

Objective

To ensure compliance with the AHR Act legislative and regulatory framework.

Description

AHRC would achieve this objective by the following means:

• issuing licenses for controlled activities and for facilities used by qualified persons or organizations;
• conducting periodic inspections of AHR clinics, service providers or research to ensure compliance; and
• enlisting the participation or support of other recognized organizations in the development of other supporting policy instruments (e.g., standards, guidelines, accreditation models, etc.).

Key Results

The preliminary key results for this program activity include:

• an effective licensing and inspection regime;
• compliance in respect of prohibitions and controlled activities; and
• improved safety and success of the controlled activities undertaken.

In support of the above, the Agency:

• entered into an MOU with the Health Canada Inspectorate to provide inspection services;
• developed a process to respond to complaints under the AHR Act;
• consulted with key stakeholders;
• commenced an audit for compliance with Section 8 of the AHR Act (Consent to Use);
• filled key positions through interchanges and secondments from other departments; and
• contracted the services of expert consultants in key functional areas.

Program Activity: Health Information and Knowledge Management for Assisted Human Reproduction Technologies.

Financial Resources (in $ thousands)

Planned Spending	Authorities	Actual Spending
7,400	7,400	1,847

Human Resources

Planned	Actual	Difference
22 FTEs	3 FTEs	19 FTEs

Objective

To become a centre of expertise and focal point of AHR information for policymakers, practitioners, patients, children born of AHR procedures, researchers and the Canadian public.

Description

AHRC would achieve this objective by the following means:

• developing and maintaining a personal health information registry (PHIR) to consolidate health reporting information concerning donors, patients and children born of AHR procedures to allow for a look-back and trace-back mechanism;
• providing ongoing reports of AHR controlled activities, including success rates by AHR clinics and results of research, to enable prospective AHR users to make informed decisions; and
• providing public information on AHR matters or issues via a public Web site and in other forms such as brochures.

Key Results

The preliminary key results for this program activity include:

• a confidential and secure PHIR;
• improved information for decision-making by practitioners and prospective users of AHR procedures;
• improved access by children born of AHR procedures to information on their genetic history; and
• increased awareness of the Canadian public of AHR issues or problems.

The Personal Health Information Registry (PHIR) will provide AHRC with the information to perform a number of important functions mandated under the Act as well as forming an essential part of an AHR health surveillance system.

With respect to the PHIR, AHRC sought to make progress towards the priority above by concentrating its efforts on the following:

• surveying the AHR clinics and working with the representative association towards a common vision for the collection and management of HRI through the establishment of a working group; and
• initiating development of a model framework for the PHIR.

With respect to health surveillance, AHRC sought to make progress by:

• reviewing provincial and federal surveillance systems as well as international examples such as the U.K. model;
• consulting health surveillance experts in the Public Health Agency of Canada, Canadian Institute of Health Information and Statistics Canada;
• consulting provincial bodies to assess interest in a pilot project linking an AHRC-based health surveillance system to provincial perinatal surveillance systems; and
• identifying options regarding a future Canadian health surveillance system, including required content and approaches to collection and management.

• Previous Page
• Table of Contents
• Next Page